John P. Beilby

发表

Supplementary Material 6

Jianxin Shi, Mark I. McCarthy, Karen L. Mohlke, 2014 .

Genomic Testing for Human Health and Disease Across the Life Cycle: Applications and Ethical, Legal, and Social Challenges

John P. Beilby, Gareth Baynam, Gemma A. Bilkey, 2019, Front. Public Health.

Cholesteryl ester transfer protein gene haplotypes, plasma high-density lipoprotein levels and the risk of coronary heart disease

Lyle J. Palmer, John P. Beilby, Pamela A. McCaskie, 2007, Human Genetics.

Investigating the association between K198N coding polymorphism in EDN1 and hypertension, lipoprotein levels, the metabolic syndrome and cardiovascular disease

Steven Wiltshire, Kim W. Carter, Lyle J. Palmer, 2008, Human Genetics.

FTO genotype is associated with phenotypic variability of body mass index

Joel Eriksson, Joseph E. Powell, Andres Metspalu, 2012, Nature.

Association of Interleukin-1 gene polymorphisms with central obesity and metabolic syndrome in a coronary heart disease population

Steven Wiltshire, Kim W. Carter, Lyle J. Palmer, 2008, Human Genetics.

15-Lipoxygenase gene variants are associated with carotid plaque but not carotid intima-media thickness

Lyle J. Palmer, John P. Beilby, Pamela A. McCaskie, 2008, Human Genetics.

Association of PARL rs3732581 genetic variant with insulin levels, metabolic syndrome and coronary artery disease

Steven Wiltshire, Kim W. Carter, Lyle J. Palmer, 2008, Human Genetics.

Prevalence and risk factor correlates of elevated C-reactive protein in an adult Australian population.

Matthew W. Knuiman, John P. Beilby, Joseph Hung, 2008, The American journal of cardiology.